文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

美索巴莫与地西泮治疗急诊急性下背痛:一项随机双盲临床试验

Methocarbamol versus diazepam in acute low back pain in the emergency department: a randomised double-blind clinical trial.
PubMed 文献 · Emerg Med J · 2023-04-17
一句话结论急诊急性下背痛患者中,地西泮60分钟镇痛效果略优于美索巴莫,但嗜睡风险更高(29.4% vs 4.0%)。

这项在伊朗3个急诊科开展的多中心随机双盲临床试验,纳入101例18岁以上、6周内发生下背痛的患者,比较静脉美索巴莫与静脉地西泮(两组随后均按体重给予静脉吗啡)的镇痛效果与不良反应。结果显示两组60分钟后疼痛评分均下降,地西泮组降幅略大(平均差值-6.1,95%CI -6.5至-5.7 vs -5.2,95%CI -5.7至-4.7,p<0.001)。急诊停留时间两组无差异(美索巴莫5.9小时 vs 地西泮4.8小时,p=0.365)。地西泮组嗜睡更常见(2例(4.0%)vs 15例(29.4%),p=0.001)。作者认为地西泮更有效但嗜睡风险略高。

要点

  • 在急诊急性下背痛患者中,静脉地西泮60分钟疼痛降幅略大于静脉美索巴莫(平均差值-6.1,95%CI -6.5至-5.7 vs -5.2,95%CI -5.7至-4.7,p<0.001)。
  • 地西泮组嗜睡发生率高于美索巴莫组(15例(29.4%)vs 2例(4.0%),p=0.001)。
  • 两组急诊停留时间无差异(美索巴莫5.9小时 vs 地西泮4.8小时,p=0.365)。
  • 两组均在肌肉松弛剂后按体重给予静脉吗啡,60分钟后疼痛评分均下降。
  • 研究纳入18岁以上、6周内下背痛患者,排除非脊柱病因、脊髓压迫、急性消化道出血、肝肾不全、妊娠、哺乳及生命体征不稳定者。

适用人群与场景

  • 年龄18岁及以上、过去6周内发生下背痛的患者,就诊于伊朗3个急诊科(2020年8月至11月)。
  • 排除标准包括非脊柱病因、脊髓压迫、急性消化道出血、肾功能或肝功能不全、妊娠、哺乳及生命体征不稳定。

处置流程与药物剂量

  • 第1组:静脉给予美索巴莫;第2组:静脉给予地西泮;两组随后均按体重给予静脉吗啡。
  • 在基线、30分钟和60分钟由未参与患者访视且对干预设盲的研究者用数字评定量表(NRS)测量疼痛评分和不良事件。

研究设计与关键结果

  • 多中心随机双盲临床试验,在伊朗3个急诊科开展,共纳入101例患者,美索巴莫组50例、地西泮组51例。
  • 两组基线平均疼痛评分和人口学特征无差异。
  • 60分钟后两组疼痛评分均下降,地西泮组降幅略大于美索巴莫组(平均差值-6.1,95%CI -6.5至-5.7 vs 平均差值-5.2,95%CI -5.7至-4.7,p<0.001)。
  • 急诊停留时间两组无差异(美索巴莫5.9小时 vs 地西泮4.8小时,p=0.365)。
  • 地西泮组嗜睡报告率高于美索巴莫组(2例(4.0%)vs 15例(29.4%),p=0.001)。

证据类型、等级与局限

  • 证据类型:多中心随机双盲临床试验。

对床旁实践的改变

  • 作者认为,在急诊下背痛患者中,美索巴莫和地西泮均可在60分钟内缓解疼痛;地西泮更有效,但使用地西泮与略高的嗜睡风险相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Acute low back pain (LBP) is a common complaint in the emergency department and achieving effective analgesia can be challenging.

METHODS: In this multicentre randomised double-blind clinical trial conducted at three EDs in Iran from August to November 2020, we assessed the efficacy and adverse effects of two muscle relaxants in patients aged 18 years or older who suffered LBP in the last 6 weeks. Group 1 received intravenous methocarbamol and group 2 received intravenous diazepam followed by a weight-based dose of intravenous morphine in both groups. Exclusion criteria mainly included non-spine aetiologies, cord compression, acute gastrointestinal bleeding, renal/hepatic insufficiency, pregnancy, breast feeding and unstable vital signs. Pain scores and adverse events were measured by a Numeric Rating Scale (NRS) at baseline and after 30 and 60 min by one of the researchers who was not involved with patient visits and was blinded to the intervention. We used t-test to assess the mean difference of NRS at 30 and 60 min.

RESULTS: Out of 101 enrolled patients, 50 participants received methocarbamol and 51 diazepam. The baseline mean pain scores and demographic characteristics were not different between the study groups. Pain scores were reduced by both agents after 60 min, with slightly greater pain reductions in the diazepam group in comparison with methocarbamol (mean difference -6.1, 95% CI -6.5 to -5.7 vs mean difference -5.2, 95% CI -5.7 to -4.7, respectively, p<0.001). ED length of stay of patients did not differ between the groups (methocarbamol 5.9 vs diazepam 4.8 hours, p=0.365). Patients receiving diazepam were more likely to report drowsiness (2 (4.0%) vs 15 (29.4%), p=0.001).

CONCLUSIONS: In patients with LBP, the pain was relieved in the methocarbamol and diazepam groups after 60 min. Although diazepam was more effective, its use was associated with a slightly higher risk of drowsiness.

TRIAL REGISTRATION NUMBER: The protocol of this clinical trial was prospectively registered in the irct.ir (IRCTID: IRCT20151113025025N4; https://irct.ir/trial/50148) .

来源:Emerg Med J,查看原文。版权归原作者所有。

参考来源

  1. Sharifi M, Abdorazzaghnejad A, Yazdchi M, et al. Methocarbamol versus diazepam in acute low back pain in the emergency department: a randomised double-blind clinical trial. Emerg Med J. 2023. PMID: 37068928. doi:10.1136/emermed-2021-211485

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。